{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Buffalo Grove",
      "state": "IL",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Devices",
      "event_id": "88453",
      "recalling_firm": "Leica Microsystems, Inc.",
      "address_1": "1700 Leider Ln",
      "address_2": "N/A",
      "postal_code": "60089-6622",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "E-Mail",
      "distribution_pattern": "US Nationwide distribution.",
      "recall_number": "Z-2481-2021",
      "product_description": "BOND Ready-To-Use Primary Antibody CDX2 (EP25), REF PA0375",
      "product_quantity": "237 units",
      "reason_for_recall": "Product may not perform as specified in IFU.",
      "recall_initiation_date": "20210730",
      "center_classification_date": "20210916",
      "termination_date": "20230622",
      "report_date": "20210922",
      "code_info": "Product Code PA0375, Lot 69909",
      "more_code_info": ""
    }
  ]
}